Cargando…
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival
Colorectal cancer (CRC) is one of the most common cancer worldwide, with a growing impact on public health and clinical management. Immunotherapy has shown promise in the treatment of advanced cancers, but needs to be improved for CRC, since only a limited fraction of patients is eligible for treatm...
Autores principales: | Sorrentino, Carlo, D’Antonio, Luigi, Fieni, Cristiano, Ciummo, Stefania Livia, Di Carlo, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716410/ https://www.ncbi.nlm.nih.gov/pubmed/34975867 http://dx.doi.org/10.3389/fimmu.2021.778329 |
Ejemplares similares
-
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival
por: D'Antonio, Luigi, et al.
Publicado: (2023) -
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome
por: Sorrentino, Carlo, et al.
Publicado: (2021) -
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs
por: Ciummo, Stefania Livia, et al.
Publicado: (2021) -
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
por: Sorrentino, Carlo, et al.
Publicado: (2022) -
Hindering triple negative breast cancer progression by targeting endogenous interleukin‐30 requires IFNγ signaling
por: Sorrentino, Carlo, et al.
Publicado: (2021)